Cargando…

Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials

BACKGROUND: Evolution of gadolinium-enhancing lesions into chronic black holes (CBH) may be reduced by interferon (IFN) therapy. OBJECTIVE: The objective of this paper is to assess the effect of IFN β-1a and placebo on CBH evolution and disability in patients with relapsing–remitting multiple sclero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traboulsee, A, Li, DKB, Tam, R, Zhao, G, Riddehough, A, Fang, J, Dangond, F, Kappos, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734469/ https://www.ncbi.nlm.nih.gov/pubmed/29276624 http://dx.doi.org/10.1177/2055217317745340

Ejemplares similares

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS
por: Freedman, Mark S., et al.
Publicado: (2019)

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis()
por: Tam, Roger C., et al.
Publicado: (2012)

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study
por: Traboulsee, Anthony, et al.
Publicado: (2018)

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
por: Traboulsee, Anthony, et al.
Publicado: (2018)

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study
por: Traboulsee, A, et al.
Publicado: (2008)

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
por: Kappos, Ludwig, et al.
Publicado: (2015)

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
por: Dwyer, Michael G., et al.
Publicado: (2015)

Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland
por: Järvinen, Elina, et al.
Publicado: (2019)

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS
por: Scagnolari, Carolina, et al.
Publicado: (2014)

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
por: Kolind, Shannon, et al.
Publicado: (2022)

Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials
por: Zhao, Yinshan, et al.
Publicado: (2015)

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study
por: Singer, Barry, et al.
Publicado: (2012)

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a
por: Havrdová, Eva, et al.
Publicado: (2018)

Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2022)

Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis
por: Traboulsee, Anthony L, et al.
Publicado: (2016)

Black hole physics beyond the black hole spacetimes
por: Ahmed, M
Publicado: (2002)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Black holes
por: Luminet, Jean Pierre
Publicado: (1992)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Effects of Postponing Treatment in the Second Year of Cladribine Administration: Clinical Trial Simulation Analysis of Absolute Lymphocyte Counts and Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis
por: Terranova, Nadia, et al.
Publicado: (2018)

What would you love to see sucked up by a black hole this week?
Publicado: (2008)

From black bodies to black holes
Publicado: (1977)

From black clouds to black holes
por: Narlikar, Jayant Vishnu
Publicado: (1995)

From black clouds to black holes
por: Narlikar, Jayant Vishnu
Publicado: (2012)

Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
por: Kamm, Christian Philipp, et al.
Publicado: (2012)

Black holes at CERN
Publicado: (1972)

Astrophysical black holes
por: Haardt, Francesco, et al.
Publicado: (2016)

Black holes and supersymmetry
por: Andrianopoli, Laura, et al.
Publicado: (2014)

Black holes and qubits
Publicado: (2010)

Black hole gravitohydromagnetics
por: Punsly, Brian
Publicado: (2001)

Black holes explained /
por: Filippenko, Alexei V.
Publicado: (2009)

Black holes: an introduction
por: Rain, Derek, et al.
Publicado: (2010)

Black Holes at LHC
por: Parker, MA
Publicado: (2011)

Black hole uncertainties
por: Danielsson, Ulf H.
Publicado: (1993)

Black holes and the universe
por: Novikov, Igor Dmitrievich
Publicado: (1990)

Black holes in the Superworld
por: Andrianopoli, Laura, et al.
Publicado: (2012)

Black hole complementarity
por: Thorlacius, L
Publicado: (1994)

Interpolating black holes
por: Husain, V
Publicado: (1996)

Black holes and the universe
por: Novikov, Igor Dmitrievich, et al.
Publicado: (1995)

The physics of black holes
por: Susskind, Leonard
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_t8og6hj2s32db4v39k88g6mto2